@article{Zhu2027, 
author = {Wen-Qi Zhu and Lin-Song Li and Kun Li and Bang-Bang Liu and Dong Cheng and Mei-Xia Zhao},
title = {Cascade-amplified cuproptosis in hepatocellular carcinoma via a smart hollow mesoporous CuS nanoplatform enabling synergistic phototherapy/chemodynamic therapy/starvation therapy},
year = {2027},
journal = {Nano Research},
volume = {20},
number = {1},
pages = {94909207},
keywords = {immunotherapy, cuproptosis, cascade reaction, nanozyme, mild photothermal therapy},
url = {https://www.sciopen.com/article/10.26599/NR.2026.94909207},
doi = {10.26599/NR.2026.94909207},
abstract = {Emerging copper-mediated lethal mechanisms provide cancer therapies, with current research emphasizing precise copper regulation to enhance its dual role in tumor pathology. Here, we presented a bimetallic nanoplatform, HMCuS/Ru/ICG/GOx@9R-P201Ti (HRIG9R), designed to amplify cuproptosis for hepatocellular carcinoma (HCC) therapy. Upon 808 nm near-infrared (NIR) irradiation, the mild photothermal effect enhanced cytotoxic T-cell differentiation. Concurrently, glucose oxidase (GOx) depletes glucose and generats hydrogen peroxide (H2O2), fueling Ru-mediated chemodynamic therapy (CDT) and reducing Cu2+ to toxic Cu+ to potentiate cuproptosis. This synergistic cascade—integrating starvation, CDT, and adenosine triphosphate (ATP) depletion—reprogrammed the tumor immune microenvironment and induced immunogenic cell death (ICD). These findings highlight the HMCuS/Ru/ICG/GOx@9R-P201Ti nanoplatform as a potent strategy to enhance cuproptosis-based anticancer immunotherapy.}
}